Beta Drugs Ltd vs Kwality Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1320 as of 05 May 15:30 . The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 yearsThe P/E Ratio of Kwality Pharmaceuticals Ltd changed from 3.8 on March 2021 to 22.6 on March 2025 . This represents a CAGR of 42.84% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 115.37 crore on March 2021 to ₹ 1923 crore on March 2025 . This represents a CAGR of 75.55% over 5 yearsThe Market Cap of Kwality Pharmaceuticals Ltd changed from ₹ 58.11 crore on March 2021 to ₹ 901.74 crore on March 2025 . This represents a CAGR of 73.05% over 5 years The revenue of Beta Drugs Ltd for the Dec '25 is ₹ 89.58 crore as compare to the Sep '25 revenue of ₹ 106.37 crore. This represent the decline of -15.78% The revenue of Kwality Pharmaceuticals Ltd for the Dec '25 is ₹ 123.97 crore as compare to the Sep '25 revenue of ₹ 111.95 crore. This represent the growth of 10.74% The ebitda of Beta Drugs Ltd for the Dec '25 is ₹ 19.3 crore as compare to the Sep '25 ebitda of ₹ 24.3 crore. This represent the decline of -20.58% The ebitda of Kwality Pharmaceuticals Ltd for the Dec '25 is ₹ 29.65 crore as compare to the Sep '25 ebitda of ₹ 26.25 crore. This represent the growth of 12.95% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 8.52 crore over 5 quarters. This represents a CAGR of -3.86% The net profit of Kwality Pharmaceuticals Ltd changed from ₹ 8.35 crore to ₹ 16 crore over 7 quarters. This represents a CAGR of 45.01% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kwality Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
With little background of finished pharmaceuticals and high held spirits and will, he started this business.
He received his first drug license in 1981 approved for liquid oral manufacturing.
Presently, the Company has 56 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

FAQs for the comparison of Beta Drugs Ltd and Kwality Pharmaceuticals Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Kwality Pharmaceuticals Ltd?

Market cap of Beta Drugs Ltd is 1,338 Cr while Market cap of Kwality Pharmaceuticals Ltd is 1,720 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Kwality Pharmaceuticals Ltd?

The stock performance of Beta Drugs Ltd and Kwality Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Kwality Pharmaceuticals Ltd?

As of May 5, 2026, the Beta Drugs Ltd stock price is INR ₹1320.0. On the other hand, Kwality Pharmaceuticals Ltd stock price is INR ₹1658.15.

How do dividend payouts of Beta Drugs Ltd and Kwality Pharmaceuticals Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Kwality Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.